Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population
- PMID: 18194908
- DOI: 10.1016/S0929-6646(08)60078-9
Taiwanese version of the EQ-5D: validation in a representative sample of the Taiwanese population
Abstract
Background/purpose: We know of no validated Taiwanese-language instrument to measure a utility of the patient's health. Our aim was to evaluate the reliability and validity of a Taiwanese version of the EuroQol instrument (EQ-5D) in a Taiwanese population.
Methods: Questionnaires containing the Taiwanese versions of the EQ-5D and the Short-Form 12 Health Survey (SF-12) were sent to 12,923 people in Taiwan in December 2002. Concurrent validity of the EQ-5D was analyzed by assuming that subjects with problems in any EQ-5D dimensions had decreased SF-12 scores. Discriminant validity of the EQ-5D was analyzed by assuming that subjects with the following characteristics had lowered EQ-5D indexes and scores on the EQ-5D visual analog scale (VAS): more chronic diseases than others, serious illness, more hospitalizations in the past year than others, poor general health, and more outpatient visits than others. Test-retest reliability was analyzed in a subgroup of respondents who were evaluated twice within a month by using the intraclass correlation coefficient and the kappa method.
Results: The general survey response rate was 12.7% (1644 of 12,923). SF-12 scores were lower in subjects reporting problems on EQ-5D dimensions than in others without such problems (p < 0.01). Subjects with more health problems than others had lower EQ-5D indexes and VAS scores (p < 0.01). The physical dimension of the EQ-5D was more strongly correlated with the SF-12 Physical Component Summary than with the Mental Component Summary; this finding satisfied the a priori hypothesis. For test-retest reliability of items on the EQ-5D, kappa values ranged from 0.49 to 1 (p < 0.001).
Conclusion: The Taiwanese EQ-5D instrument appears to be a moderately valid and reliable tool for measuring the health status of the general population in Taiwan.
Similar articles
-
Validity of EQ-5D in general population of Taiwan: results of the 2009 National Health Interview and Drug Abuse Survey of Taiwan.Qual Life Res. 2015 Oct;24(10):2541-8. doi: 10.1007/s11136-015-0978-7. Epub 2015 Apr 2. Qual Life Res. 2015. PMID: 25833013
-
Validity of the EuroQoL (EQ-5D) instrument in a Greek general population.Value Health. 2008 Dec;11(7):1162-9. doi: 10.1111/j.1524-4733.2008.00356.x. Epub 2008 May 16. Value Health. 2008. PMID: 18489492
-
Validation of the EQ-5D in a general population sample in urban China.Qual Life Res. 2012 Feb;21(1):155-60. doi: 10.1007/s11136-011-9915-6. Epub 2011 Apr 20. Qual Life Res. 2012. PMID: 21505881
-
Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments.Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):207-19. doi: 10.1586/14737167.2016.1146594. Epub 2016 Feb 18. Expert Rev Pharmacoecon Outcomes Res. 2016. PMID: 26808097 Review.
-
[The Spanish version of EuroQol: a description and its applications. European Quality of Life scale].Med Clin (Barc). 1999;112 Suppl 1:79-85. Med Clin (Barc). 1999. PMID: 10618804 Review. Spanish.
Cited by
-
Self-reported psychopathology and health-related quality of life in heroin users treated with methadone.Neuropsychiatr Dis Treat. 2013;9:41-8. doi: 10.2147/NDT.S37284. Epub 2012 Dec 27. Neuropsychiatr Dis Treat. 2013. PMID: 23293525 Free PMC article.
-
Survival-Weighted Health Profiles in Nasopharyngeal Cancer Patients.Front Oncol. 2021 Mar 15;11:635667. doi: 10.3389/fonc.2021.635667. eCollection 2021. Front Oncol. 2021. PMID: 33791219 Free PMC article.
-
Evaluation of health-related quality of life using EQ-5D in China during the COVID-19 pandemic.PLoS One. 2020 Jun 18;15(6):e0234850. doi: 10.1371/journal.pone.0234850. eCollection 2020. PLoS One. 2020. PMID: 32555642 Free PMC article.
-
Mapping algorithms for predicting EuroQol-5D-3L utilities from the assessment test of chronic obstructive pulmonary disease.Sci Rep. 2022 Dec 3;12(1):20930. doi: 10.1038/s41598-022-24956-2. Sci Rep. 2022. PMID: 36463253 Free PMC article.
-
A pilot randomized controlled trial to improve geriatric frailty.BMC Geriatr. 2012 Sep 25;12:58. doi: 10.1186/1471-2318-12-58. BMC Geriatr. 2012. PMID: 23009149 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous